Christopher Lobo
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Kasi S. Sridhar (1 shared paper)Roy D. Altman (1 shared paper)Orlando Silva (3 shared papers)Gilberto Lopes (3 shared papers)Stefan Glück (4 shared papers)Catherine F. Welsh (2 shared papers)Vikas Malik (1 shared paper)Joyce M. Slingerland (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)European Archives of Oto-Rhino-Laryngology (2 papers)CHEST Journal (1 paper)Biomedicine & Pharmacotherapy (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- United StatesIrelandSingapore
In The Last Decade
Christopher Lobo
9 papers receiving 179 citations
Peers
Comparison fields: 5 of 50
- Oncology 90
- Cancer Research 44
- Rheumatology 39
- Dermatology 14
- Infectious Diseases 22
Countries citing papers authored by Christopher Lobo
This map shows the geographic impact of Christopher Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lobo more than expected).
Fields of papers citing papers by Christopher Lobo
This network shows the impact of papers produced by Christopher Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lobo. The network helps show where Christopher Lobo may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Lobo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 68 | |
| 2 | 1998 | 62 | |
| 3 | 2010 | 27 | |
| 4 | 2007 | 16 | |
| 5 | 2008 | 9 | |
| 6 | 2011 | 6 | |
| 7 | 2020 | 3 | |
| 8 | 2012 | 2 | |
| 9 | 2006 | 2 |
About Christopher Lobo
Christopher Lobo is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Infectious Diseases, having authored 9 papers that have together received 195 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Breast Cancer Treatment Studies (2 papers), Nasolacrimal Duct Obstruction Treatments (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Tendon Structure and Treatment (1 paper) and Orthopedic Surgery and Rehabilitation (1 paper). The work is most often cited by research in Oncology (90 citations), Cancer Research (44 citations), Rheumatology (39 citations), Dermatology (14 citations) and Infectious Diseases (22 citations). Christopher Lobo has collaborated with scholars based in United States, Ireland and Singapore. Frequent co-authors include Kasi S. Sridhar, Roy D. Altman, Orlando Silva, Gilberto Lopes, Stefan Glück, Catherine F. Welsh, Vikas Malik, Joyce M. Slingerland, Isildinha M. Reis and Judith Hurley. Their work appears in journals such as Journal of Clinical Oncology, European Archives of Oto-Rhino-Laryngology, CHEST Journal, Biomedicine & Pharmacotherapy and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.